Schlesinger Sarah J. 4

What Happened

• Sarah J. Schlesinger, a director of Armata Pharmaceuticals (ARMP), received a grant of 25,640 derivative shares (stock options) on March 9, 2026. The reported acquisition price is $0.00 (award), so no cash was paid at grant.

Key Details

• Transaction date: 2026-03-09 (Form 4 filed 2026-03-11; appears timely within the 2-business-day filing window).
• Transaction type: Grant / Award of derivative securities (code A).
• Amount: 25,640 stock options; reported acquisition value: $0.00.
• Vesting: Footnote states the stock options will vest in full on March 9, 2027, subject to continuous service through that date.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Exercise price / other terms: Not listed in the provided excerpt.

Context

• These are option awards, not open-market purchases or sales. The options vest in one year (per the footnote) and generally must vest before they can be exercised; the filing does not indicate any immediate sale or cashless exercise. Awards to directors are common as compensation and do not by themselves indicate a short-term trading signal.